Gorha-Stout Disease of the upper jaw: case report and review of the literature

  • ALESSANDRO Moro Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
  • UMBERTO Garagiola Department of Biomedical Surgical and Dental Sciences, Maxillo-Facial and Odontostomatology Unit, Fondazione Cà Granda IRCCS Ospedale Maggiore Policlinico, University of Milan. Milan, Italy
  • GIANMARCO Saponaro Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
  • GIULIO Gasparini Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
  • ROBERTO Boniello Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
  • MARCO Falchi Ospedale „S. Giovanni Battista”, Foligno (PG), Italy
  • GIOVANNI Barbini Ospedale „S. Giovanni Battista”, Foligno (PG), Italy
  • ENRICO Cristallini Ospedale „S. Giovanni Battista”, Foligno (PG), Italy
  • GIUSEPPE D'Amato Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
  • BENCE Galambos Semmelweis Egyetem Arc-, Állcsont-, Szájsebészeti és Fogászati Klinika
  • SANDRO Pelo Maxillo Facial Surgery Unit, Catholic University Medical School, Rome, Italy
Keywords: vanishing bone disease, bone resorbtions, endothelial proliferation, zoledronic acid therapy

Abstract

Gorham’s disease, or vanishing bone disease, is a rare condition of unknown etiology characterized by bone absorption.
The disease can affect any part of the skeleton, however the pelvis, humerus, axial skeleton and the mandible are more
frequently involved. The mechanism of bone resorption is unclear, but localized endothelial proliferation of lymphatic vessels
is shown in osteolytic lesions The diagnosis is based on clinical, radiological and histological features after excluding
other infectious, inflammatory, endocrine and neoplastic etiological factors. Medical treatment for Gorham’s disease
includes anti-osteoclastic medications (bisphosphonates), and alpha-2b interferon, radiation therapy induced sclerosis of
the proliferating vascular tissue within the bone. Also surgical treatment options are available including resection of the
lesion and reconstruction with bone grafts and/or prostheses. We present a case of Gorham’s disease of the right maxilla
in a 67 years old female affecting the alveolar process, zygoma and the floor of the orbit. The initial clinical manifestation
at the onset of the disease was the mobility of the upper right molars, mimicking periodontal disease followed by the
worsening of a preexisting diplopia with undefined origin. The patient received a medical treatment with zoledronic acid,
vitamin D and calcium carbonate for 12 months which proved to be effective in controlling the progression of the disease.

Published
2019-06-16
How to Cite
MoroA., GaragiolaU., SaponaroG., GaspariniG., BonielloR., FalchiM., BarbiniG., CristalliniE., D’AmatoG., GalambosB., & PeloS. (2019). Gorha-Stout Disease of the upper jaw: case report and review of the literature. Hungarian Journal of Dentistry, 112(2.), 53-58. https://doi.org/10.33891/FSZ.112.2.53-58
Section
Case report